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Abstract—The outbreak of Ebola virus in recent years has
resulted in numerous research initiatives to seek new solutions
to contain the virus. A number of approaches that have been
investigated include new vaccines to boost the immune system.
An alternative post-exposure treatment is presented in this
paper. The proposed approach for clearing Ebola virus can
be developed through a microfluidic attenuator, which contains
the engineered bacteria that traps Ebola flowing through the
blood onto its membrane. The paper presents the analysis of
the chemical binding force between the virus and a genetically
engineered bacterium considering the opposing forces acting on
the attachment point, including hydrodynamic tension and drag
force. To test the efficacy of the technique, simulations of bacterial
motility within a confined area to trap the virus were performed.
More than 60% of the displaced virus could be collected within
15 minutes. While the proposed approach currently focuses on
in vitro environments for trapping the virus, the system can be
further developed into the future for treatment whereby blood
can be cycled out of the body into a microfluidic device that
contains the engineered bacteria to trap viruses.
Index Terms—Ebola virus, Genetically engineered bacteria,
Microfluidic viral attenuator.
I. INTRODUCTION
The recent outbreak of Ebola virus has resulted in concerns
by the research community to develop new solutions that
can curb and control their spreading process [1]. While the
majority of Ebola virus outbreaks are currently found in
Africa, their rate of spreading requires immediate attention.
The spreading process of Ebola virus is through the exchange
of fluids between individuals, animals, as well as within the
environment where the virus lies. The poor sanitary conditions
in the developing countries also fuel the spreading process,
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which has detrimental effects on lives and on the socio-
economical stability of the affected regions.
Currently, there are preventive and post-exposure treatments
available [2] [3]. Two vaccines were developed and are still
being tested in Guinea: one developed by Merck Sharp and
Dohme and another by Toyama Chemical [4], [5]. Other
advanced research for solutions to the Ebola virus disease
problem is in the domain of molecular biology and biotechnol-
ogy [6]. Based on this, a number of therapeutic medications
to treat Ebola virus disease has been developed and tested,
and this includes TKM-Ebola, amiodarone, dronedarone, ve-
rapamil and ZMapp [3], [7], [8]. ZMapp is a cocktail of
three monoclonal antibodies produced from Tobacco plants
(Nicotiana benthamiana species) and provides immunity to
the Ebola virus. Successful tests were made on mice and non-
human primates [8], [9]. Also, monoclonal antibodies derived
from a person who survived Ebola virus disease protected
non-human primates when given as late as 5 days after the
infection [10], [11]. Other treatments that have compounds
capable of blocking Ebola virus-like particles from entry into
the cells and a novel peptide vaccine have also been proposed
to increase the range of available treatments [12], [13]. While
the effectiveness of those vaccines in particular for large
scale population is still under investigation, another outbreak
can occur. Therefore, we propose an alternative post-exposure
treatment using synthetic biology to engineer bacteria that can
trap the virus, and utilize this solution through a microfluidic
attenuator.
The field of synthetic biology has received tremendous
attention in recent years, due largely to the potential impact of
delivering new solutions for biotechnology [6], [14]. Synthetic
biology enables genetic circuits to be designed and inserted
into cells in order to create new properties as well as function-
alities. For example the field of molecular communication [15],
[16] aims to construct bio-compatible communication systems
based on programming of cells. Engineered bacteria through
synthetic biology have also been used as therapeutic agents in
the past [17]. For example, HIV-1 infection in CD4+ T cells
and macrophages were inhibited using Lactobacillus jensenii
bacteria [17]. Bacteria have also been used to hunt down and
eradicate human lymphomas [18].
In this paper, we propose synthetically engineered bacteria
(Escherichia coli) that moves and traps Ebola virus in a
sponge-like manner [19]. While our theoretical models and
analysis presented in this paper are based on in vitro envi-
ronments, the proposed approach has the potential to be used
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Fig. 1: Illustration of the proposed approach, where blood containing Ebola is passed
through an external tube with a microfluidic chamber containing genetically engineered
bacteria that are used to trap the Ebola virus, (a) the microfluidic chamber is represented
as an attenuator (b) bacteria moves towards the Ebola virus scattered in the chamber, (c)
bacteria after trapping the virus once they have bind to their surface membrane.
for treatments in the future as illustrated in Figure 1. The
blood contaminated with Ebola virus are transported through a
cyclic external tube that goes through a microfluidic attenuator,
and back into the body again. Within the chamber are the
engineered bacteria that will colide and trap the Ebola through
the protein binding process on the surface membrane, resulting
in the virus attachment. The proposed system can be described
as
C ′(t) = fb(t)C, (1)
where C ′(t) is the Ebola concentration in out-going blood
flow, C is the incoming concentration of Ebola virus in the
blood stream and fb(t) is the attenuation function described
by the bacterial trapping performance.
The process of virus trapping has been investigated previ-
ously. For example, in [19] the red blood cells are used to
trap viruses. The red blood cells are ideal for virus trapping
due to the fact that they lose their DNA when grown in the
bone marrow. Therefore, when the virus infects the red blood
cell, it will have no capability of replicating itself due to
the missing DNA, and hence, leading to a trapping process.
Another example is in [20], where the authors specifically
studied the Phi-6 virus which typically invades Pseudomonas
phaseolica cell. This particular bacterium attaches itself to the
plants by using its hair like structure that extends from their
body. The attachment is achieved when the bacteria contracts
its body enabling the thick hair to grip onto the surface of
the plant. This contracting process will also lead to the virus
being able to infect the bacteria. In order to trap the virus,
the authors engineered the bacteria to have excessive amount
of hair on the surface leading to minimal amount of space to
allow the virus to penetrate through the membrane but enough
to embed and get stuck on the microbes [20].
The most common mechanism for virus binding on the
cell’s surface is through the polyvalent interactions between
the proteins and the cell’s receptors [21]. This process is
similar to what we are proposing in this paper. However,
there are a number of challenges to be addressed. First,
compatible binding process is required between the virus and






Fig. 2: Genetically engineered bacteria will produce proteins on the surface that will
allow the virus to bind.
engineered through synthetic biology as illustrated in Figure
2, where genes that are inserted into the plasmid can lead to
expression of proteins on the surface. Second, Ebola virus has
a long filamentous structure unlike other types of virus, and
usually with a higher molecular weight. Therefore, the binding
process may not cover the entire length of the virus, leading
to parts of the virus hanging from the bacterium after binding.
This means that the binding process must be strong enough
to support the momentum of the hanging virus body, and in
particular when faced with hydrodynamic tension and drag.
The contributions of this paper include:
• Design of Ebola virus microfluidic attenuator system:
a cleaning process is proposed, where the bacteria are
used to collect and trap the Ebola virus. This trapping
process will minimize the virus concentration in blood to
curb them from replicating and spreading.
• Binding force model: Developed a protein binding force
model to trap Ebola virus in free moving bacteria, con-
sidering their swimming and tumbling process, as well as
opposing forces resulting from the hydrodynamic tension
and drag and the weight of the hanging body of the virus.
• Simulation evaluation: Simulations of bacteria motility
process are conducted to evaluate the effectiveness of
trapping an Ebola virus population in a confined area.
The paper is organized as follows. Section II describes the
physical properties of Ebola virus. The engineering of proteins
on the bacteria surface to bind to the virus is presented in
Section III. Section IV describes the binding force models
between the bacteria and the virus. The simulation evaluation
and results are presented and discussed in Section V. Lastly,
Section VI presents the conclusion.
II. BACKGROUND ON EBOLA VIRUS
Ebola virus belongs to the order Mononegavirales and the
Filoviridae family. Upon infection, it can kill up to 50%
of the patients within 6 to 16 days [22]. The virus has a
filamentous shape, with a uniform width of nearly 80 nm
and a length of approximately 970 nm, and its structure is
illustrated in Fig. 3. As illustrated in Fig. 3, virus membrane
consists of GP1,2 (spike glycoprotein) and two other proteins,
VP40 and VP24 (primary and secondary matrix proteins).
GP1,2 is a membrane-spanning protein, and VP40 and VP24
builds the inner matrix [23], [24]. The glycoprotein are 7 nm
in diameter and have a spacing of 10 nm between each
other. The glycoprotein enables the Ebola virus to bind and
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submerge itself into the host cells (process required for viral
internalization) [23].
GP1,2 VP24 VP40
Fig. 3: Structure of an Ebola virus, including the membrane-spanning protein (GP1,2)
and the proteins that build the inner matrix (VP40 and VP24).
There are three infection routes for the Ebola virus: through
mucosal surfaces (mouth, eyes, genitalia), skin abrasions or
through the use of contaminated needles [24]. After the virus
enters the body, it spreads rapidly [24]–[27], and is capable of
overcoming responses from the immune system. The high rate
of virus replication inside the immune system cells hinders the
human body defenses [25]–[27]. Monocytes, macrophages and
dendritic cells are the front door for the Ebola virus infection
and preferred sites of replication [26]. In addition, these cells
are used as vehicles to spread the Ebola virus through the
lymphatic system [24]. Infected monocytes and macrophages
secrete soluble factors to recruit other similar cells inside
the lymph nodes to increase the infection. In latter stages,
hepatocytes and adrenal cortical cells are infected and the
production of coagulation factors is decreased which results
in internal bleeding [28].
III. ENGINEERING PROTEIN BINDING
A. Synthetic Protein Binding Receptors
The main challenge of lowering the concentration of the
Ebola virus using bacteria lies in using synthetic biology to
produce the required proteins on the surface membrane to bind
the virus. In particular, careful understanding of viral entry and
replication mechanisms into the host system is required before
suitable genetic circuits can be developed. Past research have
used dual color synthetic constructs to observe how a single
virus affects the host bacterium and determine the level of
infection [29]. Single-virus tracking methods have also been
developed to observe the mode of interaction between E. coli
and bacteriophage lambda [29]. In our proposed model, it is
possible to construct a synthetic gene that could increase the
expression of Ebola virus protein binding receptors. Facilitat-
ing the binding frequency between the viral proteins and over
expressed membrane receptor proteins would be an advantage
to harvest the target virus. Specifically, reports have suggested
that the cell surface receptor T-cell Immunoglobulin Mucin
domain 1 (TIM-1) of epithelial cells favourably increases
the binding of Ebola virus. A study on over expression of
fluorescent tagged TIM-3 protein in E. coli also confirms that
TIM-like protein can have a functional property which allows
viral protein recognition and binding [30]. Therefore, the TIM-
like protein could be one of the possible targets to be expressed
in E. coli to create engineered bacteria to trap the Ebola virus.
Engineering the synthetic circuit of EnvZ/OmpR/BolA genes
along with the TIM-like protein-coding genes will facilitate the
binding of Ebola virus and simultaneously control the motility
















Fig. 4: Expanded view of the partial deformation on the bacterium’s surface membrane
when the virus binds on its surface.
is the sensor-transmitter kinase that phosphorylates OmpR, a
DNA-binding regulatory protein, under stress conditions) [31],
[32]. Another requirement is the engineering of the bacteria
to prevent the virus entry, and this could be achieved by
considering the use of mutant E.coli as a host that carries
membrane proteins (e.g., Porins) [33], [34].
B. Protein Binding Model
Our model is developed as a function of the binding among
bacterial receptors and the viral glycoproteins. We analyse the
produced binding force, and how it will counter the opposing
forces (due to drag and weight of the virus) that can result in
the attachment breakage. During the binding process, the virus
deforms the bacterium’s surface creating a curved cavity with
a submergence angle φ (in radians) as shown in Fig. 4 [35].
The cavity segment consist of height h and arc length s. The
attachment area BArea between the virus and the bacterium
can be evaluated as:
BArea = s∆EL
= φER∆EL
where ER is the Ebola virus radius and ∆EL is the length
of Ebola virus that attaches to the bacterium. Therefore, the
reaction between the bacterial receptors and virus proteins
within BArea can be represented as [35]:
n[V] + m[B]
Ka−−→←−− [BmVn], (2)
where n is the number of viral proteins that binds to a single
bacterial receptor; m is the number of bacterial receptors that
binds to a single viral protein; [V] and [B] are the concen-
trations of viral proteins and bacterial receptors, respectively;
and Ka is the association binding constant for the reaction.
The initial values for the viral and bacterial proteins ([V0]
and [B0]) are the ratio between the minimum attachment area
and the area occupied by the Ebola glycoprotein and TIM-1,
respectively. Therefore, the fraction of the bacterial receptors





The total binding energy resulting from the complex for-
mation of the Ebola virus glycoprotein and the bacterium
receptors is represented as [37]:
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ETotal = (EBind + (p− 1)TaS0)BArea, (4)
where Ta is the absolute temperature; S0 is the translational
and rotational entropy of binding for this complex. The affinity
binding energy EBind can be evaluated as follows:
EBind = −pkBTa lnKa (5)
where kB is the Boltzmann constant. Based on the EBind, the





Since each virus will occupy a small area of the bacterium,
the surface area can accommodate a number of Ebola virus.
The limit for the number of virus that can bind to each
bacterium blimit can be represented as:




where bacArea is the bacterium surface area and i = 0, 1, 2, ...
is the number of attached virus.
IV. FORCE MODEL FOR VIRUS DETACHMENT
In general, to achieve the stability of attachment, the binding
force will highly depend on the opposing forces that include
hydrodynamic drag force as well as the tensions exerted on
the Ebola virus. The equilibrium will depend on BArea and
the motion realized by both bodies. After binding, both bodies
can move in a straight line or tumble in a fixed location. For
each movement, different tensions will affect the attachment.
In this section, we discuss the tensions and forces that are
exerted onto the virus during the bacterium’s movement.
A. Hydrodynamic Drag Force
The medium that we consider is the blood, where the Ebola
virus will diffuse through brownian motion. Once the Ebola
virus has attached itself to the bacterium, both are subjected
to the same hydrodynamic force (drag force) as they mobilize.
Since we model the shape of the bacterium as a cylinder, the






where ρf is the fluid medium density, v = vb − vf is the
relative velocity between the bacterium (vb) and the fluid (vf ),
A = πB2R is the bacterium’s cross-section and BR is the















where ηf is the fluid viscosity, and Dv is the width of the
microfluidic chamber.
B. Bacteria Motility
Bacteria have different types of motility, e.g., swarming,
swimming, gliding [39]. For swimming, bacteria utilises their
flagella to swim in a regular or biased motion towards a source
(e.g., nutrients). Bacteria can also move in a coordinated
manner across solid or semi-solid surfaces [39]. This motility
process is known as swarming and it is performed by group
of cells instead of single individuals. This form of motility
also depends on the pili formation that helps the cells to
aggregate into a population [39]. For our model, we consider
that the bacteria will swim and will not be allowed to grow
or attach onto other surfaces, which is based on the swarming
and gliding process. Also our aim is to allow the bacteria the
freedom of random movement to trap the Ebola virus, and this
could be achieved through their swimming process.
The swimming process of the E. coli is based on their
flagella movement. The flagella are tails that stem from the
body of the E. coli. The swimming behavior of the bacteria is
based on a cycle of run and tumble motion, and is governed
by a random walk. During swimming, the flagella will wrap
into a single body, and this will rotate as a propeller allowing
them to swim forward. The bacteria swims in a straight line
for an average period (λRun) that is based on an exponential
distribution [40]. The binding between the bacterium and virus
will occur when they come into contact with each other. After
swimming for a short period, the flagella will unwrap into
individual strands and this will lead to tumbling in a fixed
location. Once again the average tumbling period is based on
an exponential distribution (λTumble) [40]. After the tumbling
process, the bacterium will select a random angle to continue
swimming.
C. Tension Force for Running Motion
The bacterium’s running motion (see Figure 5) produces
tension on the binding area that could break the attachment. In
order to analyse the forces affecting the binding between two
bodies, we use the approach presented in [41]. The description
of each variable is as follows: ∆EL is the length of the Ebola
virus that binds to the bacterium’s surface (we are assuming
here that only a portion of the virus has bound), FM is
the force exerted by the bacterium’s flagella that enables the
movement, Wh is the weight for the hanging section of the
Ebola virus, Wdl is the weight for the bound section of the
Ebola virus, T is the tension exerted on the hanging portion of
the Ebola virus that attempts to peel it from the bacterium due
to resistance, l1 is the distance between the bound mid-section
of the Ebola virus and the bacterium’s centre of mass, l2 is
the distance between the centre of the Ebola virus hanging
section and its bound mid-section, θh is the angle between the
hanging portion of the virus and the bacterium. We consider







Wh = meg −Wdl ,
This is the author's version of an article that has been published in this journal. Changes were made to this version by the publisher prior to publication.
The final version of record is available at  http://dx.doi.org/10.1109/TCBB.2018.2836430
Copyright (c) 2018 IEEE. Personal use is permitted. For any other purposes, permission must be obtained from the IEEE by emailing pubs-permissions@ieee.org.
SUBMITTED TO IEEE/ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS 5
Fig. 5: The binding force representation model between an Ebola virus and the bacterium.
The opposing tension force T is responsible for peeling the virus from the surface of
the bacterium while the other forces act to maintain their attachment stability.
where me is the Ebola virus’ mass and g is the gravitational
constant. In order for the body to move linearly in a particular
direction, the sum of momentum has to be equal to zero.
Therefore,
∑
M = Mdl +Mh +Mg +Md −MT = 0, (11)
where Mdl = WdLl1 is the momentum due to the force
exerted on ∆EL, Mh = Wh(l2 + l1) cos θh is the momentum




Pn x dx is the momentum due to
the force exerted on the glycoprotein-receptor complexes on
the bacterium (where Pn is the adhesive pressure of all the
glycoproteins and x is the length of the Ebola virus binding
area), Md = FDrag sin θhEL is the momentum due to the
drag force exerted on the edge of the Ebola virus (FDrag
is calculated from Eq. (8)), and MT = TEL sin θh is the
momentum due to the tension exerted on the hanging section
of the Ebola virus. Replacing these terms into Eq. (11) as







, which is the
distance between the weights WdL and Wh, the tension T



















The adhesive pressure of glycoproteins (P ) can be expressed
as the force exerted within the bound area, and can be












where nG is the concentration of glycoproteins required for


























Fig. 6: Illustration of attachment points for angular and flat binding of Ebola virus on the
bacterium as its going through a tumbling process. The positions of the flat and angular
binding are dependent on the clockwise rotation of the bacterium.
.
Fig. 7: The force model of an Ebola virus on the bacterium that is going through a
tumbling process. This illustration shows the forces acting on the angular binding for
Ebola virus. The angular binding only happens on locations of turns when the Ebola
virus is being pulled outwards during the tumbling process.
D. Tension Force for Tumbling Motion
When a bacterium tumbles, depending on the position of
the Ebola virus binding point, there will be two different types
of force models, which are angular and flat binding. Figure
6 illustrates these binding points on the bacterium. As the
bacterium rotates at the centre point of the body, the angular
binding will occur when the Ebola virus encounters a pulling
force (e.g., at the front of the bacterium when it tumbles
clockwise), while the flat binding occurs at the tail end of the
body when the virus is pushed through the circular motion.
Figure 7 illustrates the force model for the angular binding,
while the flat binding model is illustrated in Figure 8.
1) Angular Binding: Since the motion is a continuous
rotational spin at a fixed point, the sum of the momentum
is represented as follows:∑
M = Iα, (14)
where I is the inertial momentum of the bacterium as well
as the Ebola virus, and the angular acceleration during the








where ft is the frequency of tumbling. Therefore, the inertial













where Ehl is the length of the virus that is hanging, mB is
the mass and L is the half length of the bacterium. For the
angular binding, considering Eq. (14) and (15), Eq. (11) can
be represented as:
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Fig. 8: The force model of the Ebola virus on the bacterium that is going through a
tumbling process. This illustration shows the forces acting on the flat binding for the
Ebola virus. The flat binding only occurs on locations of turns when the Ebola virus is
being pushed up against the bacterium during the tumbling process.

















+ FDrag sin θhEL − TEL sin θh,


































∗ (EL sin θh)−1. (16)
2) Flat Binding: For the flat binding during the tumbling
process, Eq. (16) can be simplified because there is no angle
of attachment between the Ebola virus and the bacterium. This
means that a large part of the virus will lie flat on the bacterium
during rotation. This scenario is presented in Figure 8. In this





































V. ANALYSIS AND SIMULATIONS
Firstly, we will present the analysis of the binding forces and
tensions for the virus attachment to an individual bacterium.
This will then be followed by simulations that will evaluate
the microfluidic attenuator performance of the Ebola collection
process. The values for all the parameters used in the binding
force analysis and simulations are presented in Table I.
Binding Area (m2) ×10-14




















Fig. 9: Analysis of receptor binding force for five different valency configurations.
Binding Area (m2) ×10-14

























Fig. 10: Analysis of receptor binding force for two different temperatures. The tem-
perature difference was not sufficient to produce significant changes in the attachment
force.
A. Binding Force and Tensions Analysis
The aim of the analysis is to evaluate the effect of tension
forces acting on the attachment point between the Ebola virus
and the bacterium, and how this impacts on the protein binding
force. The binding force analysis is presented in Figures 9 and
10, while the opposing forces analysis are presented in Figures
11, 12 and 13.
The binding force relies on the bacterial and viral pro-
teins valency, and its models were presented in Eg. (2)-(6).
Therefore, we considered different fixed values of n and
m to evaluate their impact on the resulting binding force
(see Figure 9). Even if the number of bonds increases, the
ratio n/m will still remain the same. For n = {1, 2} and
m = {1, 2}, the binding force was almost the same with less
than 1% difference, and this was the highest value achieved.
The chosen protein, TIM-1, can bind to two or three proteins
at same time (i. e. 1 ≤ m ≤ 3) and as presented in Figure
9, this resulted in the highest binding force values for all
possible attachment area, which also reflects the most suitable
protein configuration. In Figure 10, we analysed the effect
of temperature on the binding force. We considered three
different temperatures to observe different behaviours that can
arise. Normal human body temperature is 309.65 K and during
fever this is elevated to 313 K. The latter value is also the
average temperature of countries where the disease outbreak
occurred. As we can observe, the temperature does not produce
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TABLE I: Parameters used to evaluate the receptor binding force, tensions and drag force
applied on the bacterium as well as the Ebola virus. * Refers to values chosen by the
authors. ** Refers to standard values.
Variable Value References
ER 47× 10−9 m [22], [23]
EL 970× 10−9 m [22], [23]
BR 0.5× 10−6 m [42]
BL 1× 10−6 m [42]
vb 20× 10−6 m/s [42]
me 5.45× 10−19 kg [22], [23]
mb 1× 10−18 kg [42]
[B0] 6.7× 10−6 proteins/µm2 *
[V0] 2.8× 10−2 proteins/µm2 *
ft 1.37 tumbles/s [43]
φ from π/100 rad to π/10 rad *
Ta 310 K *
kB 0.00831446211 kJ/mol/K **
ρblood 1060 kg.m−33 [38]
g 9.8 m/s2 **
µs 3× 10−3 Pa.s **
Dv 5 cm *
significant changes in the receptor binding force behaviour,
even for high temperatures such as Ta = 336.85 K.
The opposing forces acting on the attachment area can be
increased or lowered depending on variations for a number
of parameters: blood velocity, blood viscosity and angle of
attachment between the Ebola virus and the bacterium. When
the blood enters the microfluidic chamber, it will gain a certain
velocity that could be high enough to increase the tension
on the attachment point that can lead to breakage. In Figure





and evaluated their impact on the binding force when the
bacterium is running in a straight line (worst case). As the
velocity increases, we can observe that the tension increases
as well. However, if the blood velocity is much higher than the
bacteria velocity, this can become an issue. In this case, when
the blood flows into the chamber, it will disrupt the bacterial
movement by pushing them toward the opposite border of
the compartment. To avoid this effect, the bacteria need to
be placed inside the microfluidic chamber when the blood is
at rest and removed before the blood is pumped back into the
body.
The patient’s blood can be more or less viscous depending
on their health condition. Different viscosity values can pro-
duce significant changes on the drag force that could result in
higher tension on the attachment point between the virus and
the bacterium. Figure 12 shows the effect of three different
viscosity values on the tension applied on BArea. Higher
viscous blood will have a larger impact when the bacteria
is moving, and a less viscous blood will affect the tension
when the bacteria is tumbling. For all cases presented in
Figure 12, the changes to the tension on the attachment point
is reasonably low. This result demonstrates that the blood
viscosity will not impact on the proposed attenuator system
performance. The same occurs if we change the attachment
angle, as shown for both the running and angular binding
analysis (Figure 13). For this analysis, we considered three
Binding Area (m2) ×10-14
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Fig. 11: Analysis of the effect of three different blood velocities on the tension exerted
onto the attachment area. We evaluated the opposing forces for v1f = 0 µm/s, v
2
f =
10 µm/s and v3f = 20 µm/s.
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Fig. 12: Analysis of the effect of three different blood viscosities on the tension exerted
onto the attachment area. We evaluated the opposing forces for η1f = 3 × 10
−3 Pa.s,
η2f = 4× 10
−3 Pa.s and η3f = 5× 10
−3 Pa.s.
different attachment angles between the Ebola virus and the
bacterium. As we can observe from the plots, when the angle
increases, the tension applied to detach the virus from the
bacterium decreases. Furthermore, for θ ≥ 5 rad, the angular
binding tension enhances the attachment rather than oppose to
detach the virus.
B. Microfluidic Attenuator Trapping Simulations
In order to validate the Ebola virus trapping process by the
bacteria, we conducted several simulations for the different
environments that the system could be exposed. We are
interested in evaluating the attenuator model performance for
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Fig. 13: Analysis of the angular and running binding tensions. Three different attachment
angles were considered in this analysis θ1 = 10 rad, θ2 = 5 rad, θ3 = 0.5 rad
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Fig. 14: The pickup ratio increased proportionally to the different simuation times. For
4 minutes more than 30% of the available virus were captured; for 8 minutes, more than
40%; and for 12 minutes, more than 50%.
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Fig. 15: The quantity of Ebola virus that are captured with respect to time as the quantity
of bacteria are varied. The area considered is 5x5 cm.
the initial stage of the infection, where the number of Ebola is
approximately 104 virus/ml of blood [44]. For all considered
scenarios, the Ebola virus were randomly distributed in a
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Fig. 16: The filter function fb(t) was numerically evaluated for 5000 bacteria. This
function can be used to predict the time needed to reach the desired pick-up ratio.
microfluidic chamber square area with a size of 25 cm2, while
the bacteria are placed in an external compartment.
The bacteria are released from the compartment (x = 0
and along the y-axis) swimming into the chamber to capture
the Ebola virus. In our scenario, the number of Ebola virus
is higher than the number of bacteria. To ensure a constant
blood viscosity value (3× 10−3 Pa.s), the simulation duration
was limited by the amount of time before clotting naturally
occurs, which is between 8 and 15 minutes [45]. We also
considered a static blood flow (vf = 0), small attachment
angle (θ ≤ 0.5 rad) and the binding force was generated by a
trivalent protein interaction (n = m = 3).
Based on the analysis presented in Section V-A, we found
that the attachment area has an important effect on the relia-
bility of the binding process. The area limit defined in Eq. (7)
is used to determine the maximum number of virus that can
attach to each bacterium (this is calculated by considering the
bacteria shape as a cylinder, and determining the area of each
virus that binds to the surface membrane). In our simulations,
for each contact between a bacterium and a virus we evaluate
Eq. (7). If the bacterium’s area is already full of virus, or if the
attachment area is larger than the area available, this means
that there are no remaining space on the bacterium’s surface.
The results presented in Figures 9, 10 and angular binding
tension in Figure 12, showed that an increase of BArea resulted
in larger binding force or opposing tensions. At the same
time, the results presented in Figures 11, 12 (running and flat
binding tensions) and 13 showed an inverse relationship with
BArea. Therefore, in order to simulate a realistic scenario, we
consider various random attachment area between the Ebola
virus and the bacteria.
The pick-up ratio was evaluated for different Ebola den-
sities, simulation times and quantity of bacteria. Figure 14
presents the performance of the attenuator, which is the ratio
of the average number of Ebola virus captured (104, 5× 104
and 105 virus) by 1000, 3000 and 5000 bacteria within 4, 8
and 12 minutes. As we can see from the results, the quantity
of virus is reduced with respect to the number of bacteria and
duration allowed for the collection process.
Since each bacterium will have an attachment limit in terms
of bound Ebola virus, after a certain amount of time the system
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Fig. 17: The placement of bacteria have an impact on the spatial distribution of the virus. (a) At the start of the simulation, the bacteria where placed along the y-axis (x = 0) and
the virus is randomly distributed within the chamber; (b) at 3600 seconds, bacteria could filter a small portion of the area; (c) at 7200 seconds, bacteria mobilized to more than
30% of the chamber’s length.
is expected to became saturated. The next set of experiments is
designed to measure the time required before saturation occurs.
The number of Ebola virus were fixed at 10,000 and three
quantities of bacteria were considered (1000, 3000, 5000),
while the simulation time was fixed at a maximum of 720
seconds, and the simulations were executed for 10 cycles. The
time 720 seconds is selected to avoid blood clotting. Figure 15
presents the average pick-up ratio, where after 720 seconds,
1000 bacteria achieved 37.89± 12.6% of the total number of
virus, 3000 bacteria achieved 47.41± 24.76% and 5000 bac-
teria achieved 61.15±13.56%. We can also observe in Figure
15 that the bacteria do not achieve their saturation point within
the considered period of 720 seconds. The considered number
of Ebola (and their random placement) combined with the
random nature of bacterial swimming process produce the high
variance observed, and limits the bacteria from reaching their
saturation point within 720 seconds. We previously defined the
model for the attenuator in Eq. (1), which also includes the
attenuator function fb(t) that determines the amount of Ebola
virus to be picked up as a function of time. This function can
be estimated from the saturation experiments. As an example,
considering that 5000 bacteria achieved the highest pick-up
ratio, we used this result to evaluate numerically the attenuator
function fb(t) for 10,000 virus, and predict the time required




The pick-up process can also be observed spatially. In
Figure 17, 10,000 Ebola virus were spread randomly within
the chamber (with an area of 1 cm2) and 3,000 bacteria were
released along the y-axis (x = 0). Within 720 seconds, the
number of bacteria reached approximately 5,000 µm. This also
demonstates the speed the bacteria takes to move within the
area and perform the Ebola pick-up. It can be also observed
from Figure 17 that the bacteria is able to only cover a
small portion of the area. This result suggest that a proper
chamber design is important to optmise the pick-up process.
The chamber geometry will depend on the concentration of the
virus for the desired blood volume and the number of bacteria
used to collect them. This is still a open problem that should
be addressed during the attenuator design.
VI. CONCLUSION
The emergence of Ebola virus in recent years has motivated
the need for effective treatment solutions to curb the spreading
process. In this paper, we presented an approach where bac-
teria, genetically engineered, are capable of trapping Ebola
virus that binds on its surface. The approach requires blood
to be temporarily transported through an external tube that
is connected through a microfluidic chamber containing the
engineered bacteria. Our approach includes the engineering of
receptors on the surface of the bacteria that are compatible to
the glycoproteins found on the membrane of the Ebola virus.
Our analysis found that the binding process of the Ebola virus
on the bacteria is highly dependent on the valency of both
viral and bacterial proteins as well as the attachment area. The
paper also presented a simulation model of the bacteria hunting
process of the Ebola virus within a confined area. The analysis
includes the saturation time of the Ebola virus collection pro-
cess, as well as the collection and trapping performance when
the number of bacteria and Ebola virus varies. Our results
show that for the considered simulation time, the bacteria
can collect the virus without reaching its attachment limit,
and the performance of the Ebola virus trapping quantity is
highly dependent on the number of bacteria that are deployed.
Although this paper only concentrated on the E.coli bacteria,
the approach can also extend to other attenuated strains of
bacteria such as Salmonella [46] and also to other virus that
can bind to TIM-1. The proposed technique also shows the
potential of using synthetic biology to build a biomedical
machinery to clean human blood from virus.
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